Virgo Announce Partnership to Enhance Clinical Trials Using AI Technology

Alimentiv, Satisfai Health, and Virgo Announce Strategic Partnership to Advance AI-Powered Clinical Trials in Gastroenterology

London, Ontario, Canada – October 5, 2022 – Alimentiv Inc. (“Alimentiv”), Satisfai Health, Inc. (“Satisfai”), and Virgo Surgical Video Solutions, Inc. (“Virgo”) today announced a strategic partnership to revolutionize central reading, data capture, decision support, and patient recruitment in the clinical trial domain for Inflammatory Bowel Disease (IBD) and allied GI conditions.

The partnership enables advanced AI-fueled HD video capture, decision support, and clinical research tools for Alimentiv’s global clinical trial investigator site network. Satisfai, a global leader in developing artificial intelligence solutions for gastroenterology, and Virgo, an industry leader in endoscopy video capture technology, will leverage their combined strengths to work with Alimentiv, a leading CRO in gastroenterology, to realize the full potential of AI-powered precision imaging in GI clinical trials.

“This synergy of Satisfai and Virgo with Alimentiv is a positive development for patients with IBD and the drug development space. Clinical trials have many pain points, and this strategic partnership will enable advances in improving the efficiency of clinical trials and make some significant changes to how trials are run,” said Jeff Smith, CEO of Alimentiv. “We are delighted to enter this arrangement to bring the next generation of imaging technology to clinical trials in gastroenterology.”

“Artificial Intelligence in medicine is being increasingly adopted across various clinical specialties, with gastroenterology being one key field of use, particularly endoscopy,” said Dr. Michael Byrne, CEO and founder of Satisfai Health, Clinical Professor of Medicine and gastroenterologist in Vancouver. “Working with Virgo, we are excited to bring AI-driven solutions to the IBD clinical trials arena. To be able to do so with Alimentiv — a leading gastroenterology and imaging CRO — is a great opportunity. Our clear ambition is to change the clinical trial paradigm for IBD and other disease states such as Eosinophilic Esophagitis. As three groups working together, we are confident we can do so.”

“Combining Satisfai’s marquis AI solutions with Virgo’s HIPAA- and SOC 2-compliant automated cloud video capture technology and Alimentiv’s 21CFR11-compliant solutions, expansive site community, and imaging expertise is very powerful. We truly look forward to realizing this vision and bringing real-time, in-line AI solutions to GI clinical trials worldwide,” said Matthew Schwartz, CEO and co-founder at Virgo.

This partnership will facilitate Alimentiv’s continued leadership in GI clinical trials through exclusive access to Satisfai’s SmartScore Central Reading tool and Virgo’s fully integrated, hands-free, cloud-based high-definition video-capture fleet. It will also provide pharmaceutical and biotech sponsors with access to the ongoing development of novel endpoints, scoring methodologies, and scalable solutions geared toward bringing novel therapies to market faster.

Read the official press release here.

About Alimentiv Inc.
Alimentiv is a global contract research organization (CRO) providing clinical trials, central image management, precision medicine, and real-world evidence services to the pharmaceutical and biotechnology industries. Headquartered in London, Ontario, Alimentiv employs more than 500 people across its operations in Canada, the United States, Europe, Asia-Pacific, and Latin America.

The organization’s unique model combines the efforts of internationally recognized academic researchers and operational experts to offer integrated solutions to customers. Over the past 20 years, Alimentiv has become a recognized expert in clinical trial design, central image management solutions, outcome measure development, and precision medicine for drug development in IBD.

Today, Alimentiv provides services in more than 50 countries worldwide, collaborates with leading universities and academic institutions, and partners with pharmaceutical and biotechnology organizations to bring new and improved treatment options to patients. Alimentiv is committed to advancing IBD research through innovation, technology, and regulatory-aligned clinical trial methodologies.

About Satisfai Health
Satisfai is a leading medical solutions provider specializing in AI applications for gastroenterology. Its solutions deliver real-time medical imagery analysis, providing clinicians with decision support intelligence that dramatically improves patient outcomes.

Satisfai is supported by a board of highly respected clinicians and key opinion leaders who operate at the forefront of gastroenterology. The company maintains a strong presence on academic panels, in leading GI societies, and with industry partners seeking to adopt new AI technologies.

About Virgo
Virgo provides the leading cloud video capture, management, and artificial intelligence analysis platform for endoscopic medicine. Academic, integrated, and private practice healthcare providers use the Virgo platform to advance patient care through video-based research and training initiatives.

Since launching, Virgo has helped physicians capture over 400,000 endoscopy procedures using industry-leading HIPAA, HITRUST, and SOC 2-compliant cloud services. The platform integrates seamlessly with leading electronic health records systems.

In 2021, Virgo launched Virgo Trials, a suite of tools that help pharmaceutical trial sponsors and participating trial sites accelerate patient recruitment and shorten overall trial enrollment periods.

For more information, visit virgosvs.com.